Related Experiment Video
Updated: Jun 28, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Pediatric obesity: an inflammatory condition?
1John Hancock Center for Physical Activity and Nutrition, Friedman School of Nutrition Science and Policy at Tufts University, Boston, Massachusetts 02111, USA. jennifer.sacheck@tufts.edu
Insights
Childhood obesity is rising, increasing metabolic risks like inflammation in youth. Diet and exercise may help, but more research and better biomarkers are needed to track these changes.
Area of Science:
- Pediatric Endocrinology
- Nutritional Science
- Inflammation Research
Background:
- Childhood obesity rates are increasing globally.
- This rise is linked to metabolic risk factors, including dyslipidemia and inflammation.
- These factors contribute to chronic diseases like type 2 diabetes and cardiovascular disease.
Purpose of the Study:
- To review the impact of diet and exercise on inflammation in children.
- To highlight the need for prospective studies in this area.
- To discuss the limitations of current inflammation biomarkers in youth.
Main Methods:
- Literature review of recent research on childhood obesity, inflammation, diet, and exercise.
- Analysis of current biomarkers for inflammation and metabolic risk in pediatric populations.
- Discussion of potential novel biomarkers.
Main Results:
- Elevated triglycerides and low high-density lipoprotein are common metabolic risks.
- Inflammatory biomarkers like C-reactive protein and interleukin-6 are increased in obese children.
- Dietary antioxidants, omega-3 fatty acids, physical activity, and fitness may independently reduce inflammation.
Conclusions:
- Diet and exercise interventions show promise in modifying inflammation associated with childhood obesity.
- Prospective research is crucial to confirm these effects.
- Novel biomarkers are needed to accurately detect subtle inflammatory changes in at-risk youth.
Abstract:
Childhood obesity has grown at an alarming rate, and concomitant with this rise there is an increasing prevalence of metabolic risk factors in young children and adolescents. These metabolic risk factors include elevated circulating triglycerides and low levels of high-density lipoprotein, but also an increase in inflammatory biomarkers such as C-reactive protein and interleukin-6. Each of these factors has been associated with the development of chronic diseases such as type 2 diabetes and cardiovascular disease. Recent research has indicated that dietary modifications such as increased intakes of antioxidants or omega-3 fatty acids or increased physical activity and physical fitness may independently modify the inflammation associated with excess adiposity. Additional research on the impact of diet and exercise on inflammation in children is warranted, especially studies that are prospective in nature. Finally, current biomarkers of inflammation may not be sensitive enough to detect metabolic risk in youth, and novel biomarkers may be needed to detect the subtle changes in inflammation due to diet and physical activity modifications.
Related Concept Videos
Obesity
Inflammatory Bowel Disease III: Crohn's Disease
Drug Dosing: Obese Patients
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
